CRNX

Crinetics Pharmaceuticals, Inc. is a global pharmaceutical company focused on the discovery, development, and commercialization of therapies for endocrine diseases and endocrine-related tumors. The company utilizes its expertise in the endocrine system and G-protein coupled receptors to create novel molecules aimed at improving patient outcomes. Crinetics serves patients with various endocrine conditions and operates through an in-house research and development team dedicated to advancing its therapeutic pipeline.